Anthony Fernando - Jun 8, 2021 Form 4 Insider Report for ASENSUS SURGICAL, INC. (ASXC)

Role
President and CEO, Director
Signature
/s/ Joshua Weingard, as attorney in fact for Anthony Fernando
Stock symbol
ASXC
Transactions as of
Jun 8, 2021
Transactions value $
-$1,602,204
Form type
4
Date filed
6/10/2021, 08:40 PM
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASXC Common Stock Options Exercise $0 +550K +407.03% $0.00 685K Jun 8, 2021 Direct F1
transaction ASXC Common Stock Tax liability -$829K -246K -35.88% $3.37* 439K Jun 8, 2021 Direct F2
transaction ASXC Common Stock Sale -$7.41K -2.11K -0.48% $3.51* 437K Jun 8, 2021 Direct F3
transaction ASXC Common Stock Options Exercise $150K +183K +41.94% $0.82 621K Jun 9, 2021 Direct
transaction ASXC Common Stock Sale -$568K -183K -29.55% $3.10* 437K Jun 9, 2021 Direct F4
transaction ASXC Common Stock Sale -$348K -112K -25.7% $3.10* 325K Jun 9, 2021 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASXC Restricted Stock Units Options Exercise $0 -550K -100% $0.00* 0 Jun 8, 2021 Common Stock 550K $0.00 Direct F6, F7
transaction ASXC Stock Option Options Exercise $0 -183K -33.33% $0.00 367K Jun 9, 2021 Common Stock 183K $0.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Lapse of forfeiture restrictions on one grant of restricted stock units ("RSUs") awarded on June 8, 2020.
F2 This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
F3 The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.525 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F4 The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0 to $3.19 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F5 Prior to the transactions reported on this Form 4 the reporting person owned 135,126 shares of the Company's common stock. Following the vesting and sale transactions reported on this Form 4, the reporting person increased his ownership of the Company's common stock by approximately 190,000 shares. The reporting person also holds stock options to acquire 575,269 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 278,206 shares of common stock subject to forfeiture restrictions.
F6 Each RSU represents the right to receive one share of the Registrant's common stock.
F7 Lapse of forfeiture restrictions on the 550,000 RSUs from this grant made on June 8, 2020.